Digital Content 
NEWS #PharmaBuzz
25 May 2023
// Annalee Armstrong FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/miratis-long-wait-next-lung-cancer-med-ends-phase-3-failure
24 May 2023
// PRESS RELEASE
https://ir.mirati.com/press-releases/press-release-details/2023/Mirati-Therapeutics-Provides-Update-on-the-Phase-3-SAPPHIRE-Study-Evaluating-Sitravatinib-in-Combination-with-OPDIVO/default.aspx
02 Dec 2022
// Nick Paul Taylor FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/miratis-sitravatinib-yet-improve-survival-interim-phase-3-cancer-review-pushing-back
18 Sep 2020
// BIOSPACE
https://www.biospace.com/article/releases/mirati-therapeutics-presents-phase-2-data-on-sitravatinib-in-combination-with-nivolumab-in-urothelial-cancer-at-esmo-virtual-congress/
17 Feb 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mirati-therapeutics-announces-initial-data-in-renal-cell-carcinoma-from-ongoing-investigator-sponsored-clinical-trial-of-sitravatinib-in-combination-with-nivolumab-at-the-2020-asco-genitourinary-cancers-syposium-301005654.html
24 Oct 2019
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/mirati-therapeutics-announces-presentation-of-interim-phase-2-sitravatinib-data-in-urothelial-carcinoma-and-oral-cavity-squamous-cell-carcinoma-at-the-sitc-34th-annual-meeting-300944341.html
LOOKING FOR A SUPPLIER?
Share